Abstract
ATP-gated K + channel openers produce antinociception that is attenuated by opioid receptor antagonists, indicating K-ATP openers produce antinociception, in part, via the release of endogenous opioid peptides. Utilizing the spinal perfusion method, male Sprague–Dawley rats were administered minoxidil intrathecally (i.t.) at doses ranging from 12.5 to 200 μg/rat for 3 min, tested for antinociception using the tail-flick test, and perfused with artificial cerebrospinal fluid (aCSF) to collect endogenous opioid peptides. Endogenous opioid peptide levels were measured by radioimmunoassay. Naltrindole, a δ-opioid receptor antagonist, at 4 mg/kg, subcutaneously (s.c.), blocked minoxidil-induced antinociception. β-Funaltrexamine, a μ-opioid receptor antagonist, at 100 μg/rat, partially blocked minoxidil, whereas the κ-opioid receptor antagonist nor-binaltorphimine, at a dose of 100 μg/rat, did not attenuate minoxidil. Although antagonists of the μ- and δ-opioid receptor attenuated minoxidil-induced antinociception, there was no increase in β-endorphin, an endogenous ligand with affinity for both μ- and δ-opioid receptors or [Leu 5]enkephalin, an endogenous ligand with affinity for δ-opioid receptors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.